Cytomegalovirus pp65 antigen-guided preemptive therapy with ganciclovir in solid organ transplant recipients: a prospective, double-blind, placebo-controlled study.
about
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsPre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsAntiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsPre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsOverview of the diagnosis of cytomegalovirus infection.A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant.Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage.Rapid detection and quantitation of ganciclovir resistance in cytomegalovirus quasispecies.Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation
P2860
Q24200697-8FD10A01-4C0A-46FD-B516-92B71EDE2A56Q24200991-9A6D2807-DC63-4210-B2E1-D44AAD6C1FA2Q24243124-9C3A5548-AF0B-4812-A715-FE8628471227Q24244606-FB90075F-0AD0-4369-842D-33C1E9FC1556Q37062282-66BC9FD3-0F4C-46E0-93E7-CEC3D29C05ABQ42234413-E4FF983A-E355-4B68-9582-835CAB604BDCQ45431446-F9BA3ED5-F44C-4E00-9025-ED6DDF423E75Q48039802-6397E7AE-4927-4BB6-A8B5-17C21A21D30EQ58075077-3865F82B-D4A2-44C5-B18E-3281C0A74524
P2860
Cytomegalovirus pp65 antigen-guided preemptive therapy with ganciclovir in solid organ transplant recipients: a prospective, double-blind, placebo-controlled study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Cytomegalovirus pp65 antigen-g ...... ind, placebo-controlled study.
@en
Cytomegalovirus pp65 antigen-g ...... ind, placebo-controlled study.
@nl
type
label
Cytomegalovirus pp65 antigen-g ...... ind, placebo-controlled study.
@en
Cytomegalovirus pp65 antigen-g ...... ind, placebo-controlled study.
@nl
prefLabel
Cytomegalovirus pp65 antigen-g ...... ind, placebo-controlled study.
@en
Cytomegalovirus pp65 antigen-g ...... ind, placebo-controlled study.
@nl
P2093
P1433
P1476
Cytomegalovirus pp65 antigen-g ...... ind, placebo-controlled study.
@en
P2093
Delbrück R
Furtwängler A
Meyer-König U
Neumann-Haefelin D
P304
P356
10.1097/00007890-200110150-00025
P577
2001-10-01T00:00:00Z